XML 26 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
Stock-Based Compensation
Stock-based compensation for continuing operations consisted of the following:
 
 
Three Months Ended
 
 
March 31,
(In millions)
 
2018
 
2017
Stock-based compensation expense
 
$
(0.2
)
 
$


We have stock-based compensation awards consisting of stock options, restricted stock and stock appreciation rights under four plans (collectively, the “Stock Plans”) which are described in detail in our Annual Report on Form 10-K for the year ended December 31, 2017. As of March 31, 2018, there were 129,146 shares available for grant under the 2011 Incentive Plan. No further shares were available for grant under any other stock incentive plan.
Stock Options
The following table summarizes our stock option activity:
 
 
Stock Options
 
Weighted Average Exercise Price
Outstanding December 31, 2017
 
189,466

 
$
84.81

Granted
 

 

Exercised
 

 

Canceled
 
(25,648
)
 
124.17

Forfeited
 

 

Outstanding March 31, 2018
 
163,818

 
$
78.65

Exercisable as of March 31, 2018
 
157,818

 
$
81.10


The outstanding options are non-qualified and generally have a term of ten years. The following table summarizes our weighted average assumptions used in the Black-Scholes valuation of stock options:
 
Three Months Ended
 
March 31,
 
2018
 
2017
Volatility
N/A
 
44.3
%
Risk-free interest rate
N/A
 
1.6
%
Expected life (months)
N/A
 
72

Dividend yield
N/A
 


As of March 31, 2018, there was less than $0.1 million of total unrecognized compensation expense related to non-vested stock options granted under our Stock Plans. That expense is expected to be recognized over a weighted average period of 0.8 years.
Restricted Stock
The following table summarizes our restricted stock activity:
 
 
Restricted Stock
 
Weighted Average Grant Date Fair Value Per Share
Nonvested as of December 31, 2017
 
213,982

 
$
3.53

Granted
 
77,690

 
1.33

Vested
 
(17,000
)
 
6.87

Forfeited
 
(41,992
)
 
4.78

Nonvested as of March 31, 2018
 
232,680

 
$
2.32


The cost of the awards is determined using the fair market value of the Company’s common stock on the date of the grant, and compensation is recognized on a straight-line basis over the requisite vesting period.
As of March 31, 2018, there was $0.3 million of total unrecognized compensation expense related to non-vested restricted stock granted under our Stock Plans. That expense is expected to be recognized over a weighted average period of 1.1 years.
Stock Appreciation Rights
The Company had less than 0.1 million Stock Appreciation Rights (“SARs”) outstanding at December 31, 2017. The performance targets were not met for the outstanding SARs and, as such, were subsequently canceled. As of March 31, 2018, the Company no longer has any outstanding SARs.